阿尔茨海默病生前萎缩亚型的神经病理学特征
研究纳入31例生前有MRI、死后确诊阿尔茨海默病神经病理改变的个体,分析生前萎缩亚型(典型性与严重度)与死后AD及非AD病理的关联。生前典型性与β-淀粉样蛋白、tau、α-突触核蛋白、TDP-43及病理共存呈负相关;边缘系统为主型AD较海马保留型AD有更高的Thal分期、神经炎性斑块密度和TDP-43存在。
要点
- 生前萎缩典型性与AD及非AD病理负担呈负相关(ρ=-0.39至-0.59)。
- 边缘系统为主型AD较海马保留型AD有更高Thal分期和神经炎性斑块密度。
- 典型AD较轻微萎缩AD有更高的病理共存(ρ=-0.43)。
核心结论
- 生前至死后的直接验证表明,萎缩典型性与严重度反映大脑对AD和非AD病理易感性的不同方面。
- 边缘系统为主型AD与典型AD亚型共享相似生物学通路,较海马保留型AD更易感AD和非AD病理。
研究设计与样本
- 来自阿尔茨海默病神经影像学倡议队列,纳入31例(26例AD痴呆/5例轻度认知障碍,平均年龄80岁,26%女性)。
- 纳入条件:死亡前2年内有生前MRI评估脑萎缩、生前诊断AD痴呆/轻度认知障碍、死后确诊AD神经病理改变。
- 生前萎缩亚型按典型性(边缘系统为主型AD至海马保留型AD)和严重度(典型AD至轻微萎缩AD)连续建模。
- 死后神经病理评估包括AD标志物、β-淀粉样蛋白、tau及非AD病理α-突触核蛋白和TDP-43。
- 采用偏相关分析生前萎缩亚型与死后神经病理结局的关联。
主要发现
- 生前典型性与β-淀粉样蛋白总体ρ=-0.39、tau区域性ρ=-0.38、α-突触核蛋白区域性ρ=-0.39、TDP-43总体ρ=-0.49、病理共存区域性ρ=-0.59呈显著负相关。
- 边缘系统为主型AD较海马保留型AD有更高的Thal分期、神经炎性斑块密度和TDP-43存在。
- 区域上,边缘系统为主型AD较海马保留型AD在内侧颞叶结构有更高的tau和α-突触核蛋白病理存在,在皮层下/皮层有更高的TDP-43存在和病理共存。
- 生前严重度与病理共存区域性ρ=-0.43呈显著负相关,典型AD较轻微萎缩AD有更高的病理共存。
临床怎么用
- 作者认为,理解AD基于萎缩的异质性相对于AD和非AD病理的重要性。
- 作者建议,萎缩典型性和严重度反映大脑对AD和非AD病理易感性的不同方面。
- 作者建议,边缘系统为主型AD和典型AD亚型共享相似生物学通路,较海马保留型AD更易感AD和非AD病理,后者可能遵循不同生物学通路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: To investigate whether antemortem MRI-based atrophy subtypes of Alzheimer disease (AD) differ in neuropathologic features and comorbid non-AD pathologies at postmortem. METHODS: From the Alzheimer's Disease Neuroimaging Initiative cohort, we included individuals with antemortem MRI evaluating brain atrophy within 2 years before death, antemortem diagnosis of AD dementia/mild cognitive impairment, and postmortem-confirmed AD neuropathologic change. Antemortem atrophy subtypes were modeled as continuous phenomena based on a recent conceptual framework: typicality (spanning limbic-predominant AD to hippocampal-sparing AD) and severity (spanning typical AD to minimal atrophy AD). Postmortem neuropathologic evaluation included AD hallmarks, β-amyloid, and tau as well as non-AD pathologies, alpha-synuclein and TAR DNA-binding protein 43 (TDP-43). We also investigated the overall concomitance across these pathologies. Partial correlations assessed the associations between antemortem atrophy subtypes and postmortem neuropathologic outcomes. RESULTS: In 31 individuals (26 AD dementia/5 mild cognitive impairment, mean age = 80 years, 26% females), antemortem typicality was significantly negatively associated with neuropathologic features, including β-amyloid (rho = -0.39 overall), tau (rho = -0.38 regionally), alpha-synuclein (rho = -0.39 regionally), TDP-43 (rho = -0.49 overall), and concomitance of pathologies (rho = -0.59 regionally). Limbic-predominant AD was associated with higher Thal phase, neuritic plaque density, and presence of TDP-43 compared with hippocampal-sparing AD. Regionally, limbic-predominant AD showed a higher presence of tau and alpha-synuclein pathologies in medial temporal structures, a higher presence of TDP-43, and concomitance of pathologies subcortically/cortically compared with hippocampal-sparing AD. Antemortem severity was significantly negatively associated with concomitance of pathologies (rho = -0.43 regionally), such that typical AD showed higher concomitance of pathologies than minimal atrophy AD. DISCUSSION: We provide a direct antemortem-to-postmortem validation, highlighting the importance of understanding atrophy-based heterogeneity in AD relative to AD and non-AD pathologies. We suggest that (1) typicality and severity in atrophy reflect differential aspects of susceptibility of the brain to AD and non-AD pathologies; and (2) limbic-predominant AD and typical AD subtypes share similar biological pathways, making them more vulnerable to AD and non-AD pathologies compared with hippocampal-sparing AD, which may follow a different biological pathway. Our findings provide a deeper understanding of associations of atrophy subtypes in AD with different pathologies, enhancing the prevailing knowledge of biological heterogeneity in AD and could contribute toward tracking disease progression and designing clinical trials in the future.
引用
- Mohanty R, Ferreira D, Frerich S, et al. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease. Neurology. 2022. PMID: 35609990. doi:10.1212/WNL.0000000000200573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。